House Committee requests EpiPen documents from Mylan
- Wall Street falls with financials, other post-election gainers
- The FTC Confirms Antitrust Charges Against Qualcomm (QCOM) for Monopolizing Semiconductor Device Used in Cell Phones
- United Airlines (UAL) Tops Q4 EPS by 5c
- Obama shortens sentence of Manning, who gave secrets to WikiLeaks
- After-Hours Stock Movers 01/17: (SHLO) Higher; (GIMO) (AFAM) (CSX) Lower (more...)
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S., August 24, 2016. REUTERS/Jim Bourg
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
(Reuters) - U.S. representatives Jason Chaffetz and Elijah Cummings of the House Committee on Oversight and Government Reform sent a letter to Mylan NV Chief Executive Heather Bresch on Monday asking for documents and communications related to the fast-increasing price of allergy auto-injector EpiPens.
Mylan said earlier it would launch the first generic version of EpiPen for $300, half the price of the branded product, in the drugmaker's second step in less than a week to counter a backlash over the product's steep price.
Chaffetz and Cummings, the committee's chairman and ranking member respectively, requested documents related to Mylan's revenue from sales of EpiPens since 2007, manufacturing costs and the amount the company receives from federal health care programs.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Ted Kerr)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UK consumers to be more cautious spenders, GDP growth to slow: Poll
- Greece sees progress on Cyprus, says Turkey should drop 'aggressive' talk
- Number of UK workers edges down again, but pay growth picks up pace
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!